학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 29건 | 목록 1~10
Academic Journal
Deppas JJ; Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh, Room G27e 5117 Centre Ave, Pittsburgh, PA, 15213, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.; Kiesel BF; Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh, Room G27e 5117 Centre Ave, Pittsburgh, PA, 15213, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.; Guo J; Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh, Room G27e 5117 Centre Ave, Pittsburgh, PA, 15213, USA.; Parise RA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh, Room G27e 5117 Centre Ave, Pittsburgh, PA, 15213, USA.; Clump DA; Department of Radiation Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; D'Argenio DZ; Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.; Bakkenist CJ; Department of Radiation Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh, Room G27e 5117 Centre Ave, Pittsburgh, PA, 15213, USA. beumerj@gmail.com.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA. beumerj@gmail.com.; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. beumerj@gmail.com.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Malhotra MK; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Pahuja S; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Kiesel BF; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA.; Appleman LJ; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Ding F; Biostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Lin Y; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Tawbi HA; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Stoller RG; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Lee JJ; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Belani CP; Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.; Center for Cancer Research, National Cancer Institute, Bethesda, USA.; Giranda VL; AbbVie Laboratories, North Chicago, IL, USA.; Shepherd SP; AbbVie Laboratories, North Chicago, IL, USA.; Emens LA; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Ivy SP; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Chu E; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Cancer Therapeutics Program, Montefiore Einstein Cancer Center, Bronx, NY, USA.; Beumer JH; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. beumerj@gmail.com.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. beumerj@gmail.com.; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA. beumerj@gmail.com.; UPMC Hillman Cancer Center, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA. beumerj@gmail.com.; Puhalla S; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. puhallasl@upmc.edu.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. puhallasl@upmc.edu.; UPMC Magee Women's Hospital, 300 Halket Street, Pittsburgh, PA, 15213, USA. puhallasl@upmc.edu.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Kiesel BF; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Parise RA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Krishnamurthy A; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Gore S; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.; Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0801 (Electronic) Linking ISSN: 02693879 NLM ISO Abbreviation: Biomed Chromatogr Subsets: MEDLINE
Academic Journal
Kiesel BF; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Room G27e, 5117 Centre Ave, Pittsburgh, PA, 15213, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.; Deppas JJ; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Room G27e, 5117 Centre Ave, Pittsburgh, PA, 15213, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.; Guo J; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Room G27e, 5117 Centre Ave, Pittsburgh, PA, 15213, USA.; Parise RA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Room G27e, 5117 Centre Ave, Pittsburgh, PA, 15213, USA.; Clump DA; Department of Radiation Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Bakkenist CJ; Department of Radiation Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Room G27e, 5117 Centre Ave, Pittsburgh, PA, 15213, USA. beumerj@gmail.com.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA. beumerj@gmail.com.; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. beumerj@gmail.com.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Manzo J; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Puhalla S; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Pahuja S; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Ding F; Biostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Lin Y; Biostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.; Appleman L; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Tawbi H; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Stoller R; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Lee JJ; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Diergaarde B; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.; Kiesel BF; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA.; Yu J; Department of Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, USA.; Tan AR; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Levine Cancer Institute, Charlotte, NC, USA.; Belani CP; Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.; Chew H; Division of Hematology/Oncology, Department of Medicine, University of California Davis, Sacramento, CA, USA.; Garcia AA; Department of Medicine, Louisiana State University, New Orleans, LA, USA.; Morgan RJ; Department of Molecular Pharmacology, City of Hope Beckman Research Institute, Duarte, CA, USA.; Wahner Hendrickson AE; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Visscher DW; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Hurley RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.; Kaufmann SH; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.; Swisher EM; Department of Obstetrics and Gynecologic, University of Washington, Seattle, WA, USA.; Oesterreich S; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Katz T; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Ji J; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Zhang Y; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Parchment RE; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Chen A; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Duan W; Department of Human and Molecular Genetics, The Florida International University, Miami, FL, USA.; Giranda V; AbbVie Laboratories, North Chicago, IL, USA.; Shepherd SP; AbbVie Laboratories, North Chicago, IL, USA.; Ivy SP; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Chu E; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. beumerj@gmail.com.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. beumerj@gmail.com.; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA. beumerj@gmail.com.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Kiesel BF; Cancer Therapeutics Drug Discovery Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.; Guo J; Cancer Therapeutics Drug Discovery Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.; Parise RA; Cancer Therapeutics Drug Discovery Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.; Venkataramanan R; Cancer Therapeutics Drug Discovery Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.; Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Clump DA; Department of Radiation Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Bakkenist CJ; Department of Radiation Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Beumer JH; Cancer Therapeutics Drug Discovery Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. beumerj@gmail.com.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA. beumerj@gmail.com.; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. beumerj@gmail.com.; UPMC Hillman Cancer Center, Room G27e, 5117 Centre Ave, Pittsburgh, PA, 15213, USA. beumerj@gmail.com.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Tan AR; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Antoinette.Tan@atriumhealth.org.; Atrium Health, Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA. Antoinette.Tan@atriumhealth.org.; Chan N; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Kiesel BF; University of Pittsburgh, Pittsburgh, PA, USA.; Stein MN; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Columbia University Medical Center, New York, NY, USA.; Moss RA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Bristol-Myers Squibb, Lawrenceville, NJ, USA.; Malhotra J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Aisner J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Shah M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Gounder M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Lin H; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Kane MP; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Ji J; Frederick National Lab for Cancer Research, Bethesda, MD, USA.; Chen A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Beumer JH; University of Pittsburgh, Pittsburgh, PA, USA.; Mehnert JM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; New York University Langone Health's Perlmutter Cancer Center, New York, NY, USA.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Jacobs SA; NSABP Foundation, Inc., Pittsburgh, Pennsylvania. Samuel.jacobs@nsabp.org ashok.srinivasan@nsabp.org.; Lee JJ; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; UPMC, Pittsburgh, Pennsylvania.; George TJ; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; University of Florida, Gainesville, Florida.; Wade JL 3rd; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Cancer Care Specialists of Illinois, Decatur, Illinois.; Stella PJ; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; St. Joseph Mercy Health System, Ann Arbor, Michigan.; Wang D; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Henry Ford Cancer Institute, Detroit, Michigan.; Sama AR; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.; Piette F; International Drug Development Institute (IDDI), Louvain la Neuve, Belgium.; Pogue-Geile KL; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Kim RS; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Gavin PG; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Lipchik C; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Feng H; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Wang Y; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Finnigan M; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Kiesel BF; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; UPMC, Pittsburgh, Pennsylvania.; Beumer JH; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; UPMC, Pittsburgh, Pennsylvania.; Wolmark N; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; UPMC, Pittsburgh, Pennsylvania.; Lucas PC; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Allegra CJ; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.; University of Florida, Gainesville, Florida.; Srinivasan A; NSABP Foundation, Inc., Pittsburgh, Pennsylvania. Samuel.jacobs@nsabp.org ashok.srinivasan@nsabp.org.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Joshi A; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA.; Kiesel BF; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Chaphekar N; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA.; Jones R; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Guo J; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Kunos CA; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Taylor S; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA.; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Medicine, University of Pittsburgh-Magee Women's Hospital, Pittsburgh, PA, USA.; Chu E; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Venkataramanan R; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA. rv@pitt.edu.; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, 15261, USA. rv@pitt.edu.; Beumer JH; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA. beumerj@gmail.com.; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. beumerj@gmail.com.; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. beumerj@gmail.com.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Holleran JL; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, United States. Electronic address: HollJL@UPMC.EDU.; Parise RA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, United States. Electronic address: parisera@upmc.edu.; Guo J; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, United States. Electronic address: guoxjx@UPMC.EDU.; Kiesel BF; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, United States; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address: kieselb@upmc.edu.; Taylor SE; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, United States; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Medicine, University of Pittsburgh-Magee Women's Hospital, Pittsburgh, PA, United States. Electronic address: taylorse2@upmc.edu.; Ivy SP; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States. Electronic address: ivyp@ctep.nci.nih.gov.; Chu E; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, United States; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: chue2@upmc.edu.; Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, United States; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: beumerj@gmail.com.
Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Kiesel BF
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어